Skip to main content

Syquant Capital SAS

SEC CIK
0001766392
Latest filing
Jul 9, 2026

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Syquant Capital SAS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overviewAll 13F holders of TPTXFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of TPTX by Syquant Capital SAS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−4,500−100.0%Sold outHolders
Q2 20224,500$339.0K0.4%+4,500NewHolders